Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
The company's CEO stepped down and the company reduced top-line yearly guidance.
A prospective change by the Centers for Medicare & Medicaid Services could hurt the company's revenue growth.
SILK earnings call for the period ending September 30, 2021.
SILK earnings call for the period ending June 30, 2021.
SILK earnings call for the period ending March 31, 2021.
SILK earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
